Recursion Pharmaceuticals Inc. (RXRX) is scheduled to present new preliminary data from its ongoing TUPELO study during the 2025 Digestive Disease Week meeting on May 4, 2025.TUPELO is a phase Ib/II clinical trial evaluating the safety and preliminary activity of the company's investigational drug REC-4881 for the treatment of familial adenomatous polyposis. REC-4881 is an orally bioavailable, non...
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.